dr. hamid on a retrospective analysis of pembrolizumab in melanoma
Published 5 years ago • 263 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
1:50
dr. hamid on epacadostat plus pembrolizumab in advanced melanoma
-
1:32
dr. hamid on melanoma as a therapeutic driver for other cancers
-
0:55
dr. hamid on the inclusion of patients with brain metastases on melanoma trials
-
1:06
dr. whitman on the role of pembrolizumab in melanoma
-
1:05
dr. hamid on immune therapy in melanoma
-
2:21
dr. omid hamid on vemurafenib and atezolizumab in melanoma
-
2:08
dr. hamid on exciting phase iii trials in melanoma
-
1:15
dr. hamid on tmb as a biomarker for immunotherapy response in melanoma
-
1:13
dr. hamid on immunotherapy approaches in melanoma
-
0:55
dr. hamid on patient selection for immunotherapy regimens in melanoma
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
1:19
dr. hamid on using biomarkers for immunotherapy in melanoma
-
5:54
keynote-716: adjuvant therapy with pembrolizumab for patients with high-risk stage ii melanoma
-
34:47
immuno-oncology, immune therapy, pd-1 in melanoma - omid hamid md
-
1:48
dr. hamid discusses treating melanoma
-
1:28
dr. hamid on promising triplet combinations under exploration in melanoma
-
1:08
dr. hamid on the effectiveness of immunotherapy in aya patients with melanoma
-
4:25
the phenomenon of immunotherapy in melanoma
-
11:06
esmo 2019: dr. hamid discusses exciting immunotherapy data in melanoma